Editas Medicine (0IFK) Revenue
Editas Medicine Revenue
Editas Medicine had a revenue of 11.89M in the quarter ending Jun 30, 2026, with 319.99%. This bring the company's revenue in the last twelve months to 47.01M, Increased 21.48%. In the fiscal year ending Dec 31, 2025, Editas Medicine had annual revenue of 40.52M with 25.39% growth.
- Revenue (ttm)
- 47.01M
- Revenue Growth
- 20.83%
- P/S Ratio
- 10.12
- Revenue/Employee
- $465,747
- Employees
- 87
- Market Cap
- $410.06M
Revenue Chart
Editas Medicine Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.52M | 8.21M | 25.39% |
| Dec 31, 2024 | 32.31M | -45.81M | -58.64% |
| Dec 31, 2023 | 78.12M | 58.41M | 296.32% |
| Dec 31, 2022 | 19.71M | -5.83M | -22.83% |
| Dec 31, 2021 | 25.54M | -65.19M | -71.85% |
| Dec 31, 2020 | 90.73M | 70.20M | 341.93% |
| Dec 31, 2019 | 20.53M | -11.41M | -35.71% |
| Dec 31, 2018 | 31.94M | 18.21M | 132.64% |
| Dec 31, 2017 | 13.73M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.